会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • PROCESS FOR PURIFYING 1,4,7,10-TETRA-AZACYCLODODECANE-1,4,7,10-TETRAACETIC ACID
    • 净化1,4,7,10-四氮杂环十二烷基-1,4,7,10-四氢酸的方法
    • US20170007726A1
    • 2017-01-12
    • US15116263
    • 2015-02-02
    • Agfa HealthCare NV
    • Diederik BUFFELXavier BOIJudith PYPE
    • A61K49/10B01D61/02A61K47/18C07D295/15C07F5/00
    • A61K49/108A61K47/18B01D61/027B01D2311/2649B01D2311/2673B01D2315/16C07D257/02C07D295/15C07F5/003
    • A process for purifying a compound of formula 1, includes the following steps: a) adding an acid to an aqueous solution of the compound of formula 1, including salts and hydrates thereof so as to obtain a slurry having a pH≦3; and b) filtering the slurry and at least one time washing the obtained precipitate with a liquid comprising water; and c) dissolving the precipitate obtained in step b) in water to obtain an aqueous solution; and d) filtering of the solution obtained in step c) over a nanofiltration membrane having a Molecular Weight Cut Off in the range from 150 to 500 and wherein optionally, between step c) and step d) the pH of the aqueous solution is adjusted to a pH value in the pH range as specified by the manufacturer of the nanofiltration membrane. A process for preparing a gadolinium complex of the purified compound of formula 1 is also disclosed. This gadolinium complex can be used for making a pharmaceutical composition as a contrast agent for magnetic resonance imaging.
    • 包括以下步骤:a)向式1化合物的水溶液中加入酸,包括其盐和水合物,以获得pH≤3的浆料; 和b)过滤浆料,并至少一次用包含水的液体洗涤所获得的沉淀物; 和c)将步骤b)中获得的沉淀溶解在水中以获得水溶液; 以及d)将步骤c)中获得的溶液过滤到分子量截留在150-500范围内的纳滤膜中,并且其中任选地在步骤c)和步骤d)之间,将水溶液的pH调节至 在纳米过滤膜制造商规定的pH范围内的pH值。 还公开了制备纯化的式1化合物的钆络合物的方法。 该钆络合物可用于制备用作磁共振成像的造影剂的药物组合物。